Pharmacoeconomics of mobilization
The real cost of hematological cancer care explained
COMy 2017: Day 1 discussion on progress in multiple myeloma, patient advocacy and drug costs
Arnon Nagler et al.
How is the landscape of Hodgkin lymphoma therapy changing?
What impact do side effects have on elderly chronic myeloid leukemia (CML) patients?